After years of lagging developed market (DM) returns, emerging market (EM) equities are reasserting their relevance. Energized by a weakening dollar and revised growth estimates, 2025 saw EM equities delivering their best calendar-year performance in nearly a decade. Despite these strong gains, we believe EMs remain significantly undervalued, underscoring the compelling entry point for investors today.1
In our view, there are three pillars underpinning the opportunity:
While the global macroeconomic backdrop remains rife with uncertainty, two macro levers that have historically influenced EMs are turning supportive. The U.S. dollar—long a headwind for emerging markets—is weakening, and historically, periods of dollar softness have coincided with stronger EM equity and currency performance. With the Federal Reserve shifting into a cutting cycle, marked by three consecutive 25bps rate reductions in late 2025, the dollar’s multi-year bull run appears to be peaking. A softer dollar has historically benefited EM economies due to the strong inverse correlation between the trade-weighted dollar and the relative performance of EM versus DM equities, as illustrated in Exhibit 1. As the dollar declines, the debt load for emerging economies—much of it denominated in U.S. dollars—could ease, creating room for fiscal stimulus and bolstering economic resilience.
Two other factors are also supporting the case for a weaker dollar: High carry makes EM currencies attractive relative to low-yielding developed market peers, and the U.S. dollar—now behaving more cyclically—is likely to weaken as U.S. growth slows. This environment should limit EM currency downside during U.S. growth shocks, while also enhancing their appeal amid stable or improving global risk sentiment.
And while the dollar weakens, the EM/DM growth differential widens. Emerging markets have historically outpaced developed markets in real GDP growth, a trend that looks on pace to continue. The IMF raised its 2025 outlook2 for EM and developing economies to 4.2%, reflecting resilient activity and policy credibility improvements across several EMs. In contrast, growth forecasts for DM hover at around 1.6%, with disinflation enabling monetary easing in some advanced economies—conditions that typically support risk assets and EM capital flows.
EM equities rallied for 10 consecutive months to start 2025, driven by strong earnings growth, optimism around artificial intelligence, and robust foreign investor demand. In September alone, the MSCI Emerging Markets Index rose 7%, buoyed by the Fed’s first rate cut of the year. Beyond the positive macro trends, the valuation story is perhaps the most compelling. For much of the last four decades, EM and DM relative performance has oscillated in long, multi-year cycles, each lasting, on average, nine years. The current EM underperformance cycle, at approximately 13 years, is already notably longer than the historical average, setting the stage for mean reversion. Today, forward P/E spreads show EMs trading at more than one standard deviation below DMs—a valuation gap not seen since the dot-com era and one that has historically preceded strong forward returns (Exhibit 2).
A key frustration of the past decade has been the weak translation of EM GDP growth into corporate earnings growth. Weaker corporate governance, poor capital discipline, and deficient shareholder protections have been the primary contributors to muted corporate earnings. However, the earnings drought in emerging markets appears to have bottomed out, with company fundamentals beginning to strengthen. This turnaround can be attributed to recent improvements in corporate governance and financial reforms that focus on greater capital discipline, enhanced shareholder value, investor protections, and information disclosure and transparency.
The three pillars above suggest a structural shift is underway, one that presents a strategic moment for asset allocators who understand the current investment landscape. Inefficiencies inherent to emerging markets create fertile ground for employing a disciplined, active approach to unlock potential for alpha generation.
While the emerging market indexes offer broad exposure, passive approaches may leave return on the table and add unrewarded risks. Our investment team’s analysis identifies three enduring reasons to go active—and why quantitative processes are particularly well-suited:
Emerging markets exhibit far greater stock return variability compared to developed markets, creating a wider spread between winners and losers. This higher return dispersion translates into opportunity: factor-based strategies have historically delivered stronger performance in EM than in developed markets, underscoring the value of disciplined stock selection. An active, quantitative approach can systematically identify and combine these factors into portfolios designed to harness this structural advantage. Over a 10-year period, key active factors—such as Value, Momentum, and Earnings Revisions—generated significantly higher cumulative returns in EM compared to developed markets (Exhibit 3), reinforcing why quantitative strategies thrive in these environments.
Passive, index-tracking strategies often face higher transaction costs in emerging markets due to frequent, index-driven trades and less liquid securities. In contrast, systematic active managers can execute trades more strategically, incorporating cost-aware portfolio construction—sequencing trades, using liquidity forecasts, and exploiting information advantages—to offset costs with alpha. This advantage is particularly pronounced in markets with higher fixed costs and wider bid-ask spreads, allowing active managers to preserve returns that would otherwise be eroded by inefficient trading.
Emerging market indexes are prone to significant concentration risk—by sector and by top positions—compared to developed benchmarks. For example, the MSCI Emerging Markets Index is heavily weighted toward Information Technology and Financials, creating vulnerabilities to sector-specific shocks. Systematically constructed portfolios help address sector skews, cap single name exposure, and build diversified, factor-balanced portfolios that seek to preserve upside potential while aiming to mitigate idiosyncratic shocks. Across the universe of investable EM stocks, a systematic approach can simultaneously scale the breadth of research, enforce robust risk controls, incorporate macro sensitive tilts (to currency and interest rates), and harness proven factor premia—critical for investing in a regime defined by dispersion and transition.
The confluence of historically attractive valuations, a supportive macro environment, and improving corporate fundamentals has created a powerful investment case for emerging markets. However, the unique characteristics of these markets—higher return dispersion, elevated costs, and concentration risks—necessitate a more nuanced approach than passive allocation alone. An active, systematic approach is critical to navigating the complexities and unlocking the full potential of this compelling opportunity. For investors considering a reset of their EM allocation, we believe now is an opportune moment for activation.
1 MSCI. (2026). MSCI Emerging Markets Index. Data as of December 31, 2025. Accessed January 2026.
2 International Monetary Fund (October 2025). World Economic Outlook: Global Economy in Flux, Prospects Remain Dim.
Read More
Read More
Read More
Read More
Read More
Intended for Professional and Institutional Investors only. These materials are for informational or educational purposes. All investments involve risk, including the possible loss of capital.
PGIM is the principal asset management business of Prudential Financial, Inc. (PFI), and a trading name of PGIM, Inc. and its global subsidiaries and affiliates. PGIM, Inc. is an investment adviser registered with the U.S. Securities and Exchange Commission (the “SEC”). Registration with the SEC does not imply a certain level of skill or training. PFI of the United States is not affiliated in any manner with Prudential plc, incorporated in the United Kingdom or with Prudential Assurance Company, a subsidiary of M&G plc, incorporated in the United Kingdom. Prudential, PGIM, their respective logos and the Rock symbol are service marks of PFI and its related entities, registered in many jurisdictions worldwide. For more information, please visit pgim.com.
In the United Kingdom, information is issued by PGIM Limited with registered office at Grand Buildings, 1-3 Strand, Trafalgar Square, London, WC2N 5HR, is authorised and regulated by the Financial Conduct Authority (“FCA”) of the United Kingdom (Firm Reference Number 193418). In the European Economic Area (“EEA”), information may be issued by PGIM Investments (Ireland) Limited, PGIM Netherlands B.V. or PGIM Limited depending on the jurisdiction. PGIM Investments (Ireland) Limited, with registered office at 2nd Floor, 5 Earlsfort Terrace, Dublin 2, Ireland, is authorised and regulated by the Central Bank of Ireland (Reference No. C470709) and operates on the basis of a European passport, with respect to its Italian operations by the Consob and Bank of Italy. PGIM Netherlands B.V., with registered office at Eduard van Beinumstraat 6, 1077CZ, Amsterdam, The Netherlands, is authorised by the Autoriteit Financiële Markten (“AFM”) in the Netherlands (Registration number 15003620) and operates on the basis of a European passport. In certain EEA countries, information is, where permitted, presented by PGIM Limited in reliance on provisions, exemptions or licenses available to PGIM Limited including those available under temporary permission arrangements following the exit of the United Kingdom from the European Union. This information is issued by PGIM Limited, PGIM Investments (Ireland) Limited and/or PGIM Netherlands B.V. to persons in the UK who are professional clients as defined under the rules of the FCA and/or to persons in the EEA who are professional clients as defined in the relevant local implementation of Directive 2014/65/EU (MiFID II). In Switzerland, information is issued by PGIM Limited, through its Representative Office in Zurich with registered office at Limmatquai 4, 8001 Zürich, Switzerland, is authorised and regulated by the Swiss Financial Market Supervisory Authority (“FINMA”). This information is issued to persons in Switzerland who are professional or institutional clients within the meaning of Art.4 para 3 and 4 FinSA. In Japan, information is provided by PGIM Japan Co., Ltd. (“PGIM Japan”) and/or PGIM Real Estate (Japan) Ltd. (“PGIMREJ”). PGIM Japan, a registered Financial Instruments Business Operator with the Financial Services Agency of Japan offers various investment management services in Japan. PGIMREJ is a Japanese real estate asset manager that is registered with the Kanto Local Finance Bureau of Japan. In Hong Kong, information is provided by PGIM (Hong Kong) Limited, a regulated entity with the Securities & Futures Commission in Hong Kong to professional investors as defined in Section 1 of Part 1 of Schedule 1 of the Securities and Futures Ordinance (Cap. 571). In Singapore, information is issued by PGIM (Singapore) Pte. Ltd. (“PGIM Singapore”), a regulated entity with the Monetary Authority of Singapore under a Capital Markets Services License to conduct fund management and an exempt financial adviser. This material is issued by PGIM Singapore for the general information of “institutional investors” pursuant to Section 304 of the Securities and Futures Act 2001 of Singapore (the “SFA”) and “accredited investors” and other relevant persons in accordance with the conditions specified in Section 305 of the SFA. In South Korea, information is issued by PGIM, Inc., which is licensed to provide discretionary investment management services directly to South Korean qualified institutional investors on a cross-border basis. In Australia, information is issued by PGIM (Australia) Pty Ltd (“PGIM Australia”) for the general information of its wholesale clients (as defined in the Corporations Act 2001). PGIM Australia is an Australian financial services (“AFS”) licence holder (AFS licence number 544946). The information is provided to wholesale investors in accordance with Schedule 1, Clause 3 of the Financial Markets Conduct Act 2013 in New Zealand. To invest as a wholesale investor in New Zealand, investors must fit the criteria as set out in the Financial Markets Conduct Act 2013. In China, the information is provided at your request and is not intended as investment advice or a recommendation about managing or investing assets.
GENERAL
These materials represent the views, opinions and recommendations of the author(s) regarding the economic conditions, asset classes, securities, issuers or financial instruments referenced herein. Distribution of this information to any person other than the person to whom it was originally delivered and to such person’s advisers is unauthorized, and any reproduction of these materials, in whole or in part, or the divulgence of any of the contents hereof, without prior consent of PGIM is prohibited. Certain information contained herein has been obtained from sources that PGIM believes to be reliable as of the date presented; however, PGIM cannot guarantee the accuracy of such information, assure its completeness, or warrant such information will not be changed. The information contained herein is current as of the date of issuance (or such earlier date as referenced herein) and is subject to change without notice. PGIM has no obligation to update any or all of such information; nor do we make any express or implied warranties or representations as to the completeness or accuracy or accept responsibility for errors.
These materials are not intended as an offer or solicitation with respect to the purchase or sale of any security or other financial instrument or any investment management services and should not be used as the basis for any investment decision. Past performance is no guarantee or reliable indicator of future results.
The opinions and recommendations herein do not take into account individual client circumstances, objectives, or needs and are not intended as recommendations of particular securities, financial instruments or strategies to particular clients or prospects. No determination has been made regarding the suitability of any securities, financial instruments or strategies for particular clients or prospects.
Collapse Section